SAN DIEGO, Oct. 9, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced it will
participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting
held October 16-18, 2019 in
Helsinki, Finland.
"NuVasive is driven to deliver technologies that enable less
invasive surgical techniques to patients and surgeons globally,"
said Erin McEachren, commercial vice
president of Europe at NuVasive.
"We are honored to participate as a gold sponsor at the largest
spine conference in Europe where
we will showcase our enabling technologies that advance better
patient outcomes and ultimately improve the future of spine
care."
NuVasive will host a lunch workshop, X360™, A Comprehensive
Approach to Lateral Single-Position Surgery on
Friday, October 18 from 12:00 to 2:00 p.m. EEST in Room 203 of
Messukeskus Helsinki Expo and Convention Center. Dominique Rothenfluh, a consultant spine surgeon
at Oxford University, Jake Timothy, a consultant neurosurgeon and
spine surgeon at Nuffield Hospital in Leeds
and Navin Verghese, a consultant spine surgeon at West Wales
Spine Ltd., will demonstrate the X360 system to surgeons.
NuVasive's Booth #28A will feature several of its latest
technologies, including:
- Pulse® platform – Integrated technology system that includes
neuromonitoring, surgical planning, radiation reduction, imaging
and navigation functions, with extensible capabilities for robotics
and smart tools, designed to improve a surgeon's ability to utilize
minimally invasive surgical techniques.1 NuVasive
unveiled at the September 2019 North
American Spine Society Annual Meeting its Pulse Robotics
application, which seamlessly integrates with the Pulse platform,
designed to allow surgeons to perform robotic-assisted spine
surgery.
- X360 system – Comprehensive approach to lateral single-position
surgery, which leverages advanced techniques and technologies to
deliver patient-specific care, while enhancing operating room
workflow and efficiency.
- Modulus® portfolio – Implant offerings as part of NuVasive's
Advanced Materials Science® portfolio that are intelligently
designed to combine the inherent benefits of porosity with the
advantageous material properties of titanium. NuVasive recently
launched Modulus Cervical in Europe, further expanding the Company's
portfolio of advanced implant offerings for spine procedures.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA)
is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
1 Certain applications of the Pulse platform are
under development and not available for commercial sale; robotics
and smart tools are not cleared for use by the FDA.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-as-gold-sponsor-at-the-eurospine-2019-annual-meeting-300934317.html
SOURCE NuVasive, Inc.